Overview

Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer

Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out what effects of using adaptive radiotherapy to deliver chest radiation has on the ability to control lung cancer and side effects.
Phase:
Phase 2
Details
Lead Sponsor:
AHS Cancer Control Alberta